DXCMDexCom, Inc.

DXCM Stock Price, Valuation & Chart | DexCom, Inc.

Compare

$89.690-0.45 (-0.50%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices DXCM intrinsic value DXCM calculated fair value vs price

Overview Financials Dividends Ratios

DXCM Historical price chart

DXCM Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization33.85B

PE Ratio35.17

EPS2.55

Trading Volume1.79M

Today's High/Low91.9/89.54

Dividend Yield0.00

52 Week High/Low92.59/54.11

Shares Outstanding377.36M

DXCM Financial Statement

DXCM Analyst ratings

DXCM Analysis & performance metrics

DXCM Company profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and…

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom…

DXCM Management team

Name

Position

Kevin Ronald SayerCEO

Executive Chairman, Chief Executive Officer & President

Michael Jon Brown

Executive Vice President & Chief Legal Officer

Sean Christensen

Vice President of Finance and Investor Relations

Matthew Dolan

Executive Vice President of Strategy, Corporate Development & Dexcom Labs

Leverne Marsh

Executive Vice President of Marketing

Sadie M. Stern

Executive Vice President & Chief Human Resources Officer

Jereme M. Sylvain CPACFO

Executive Vice President, Chief Financial Officer & Chief Accounting Officer

Donald M. Abbey

Executive Vice President of Global Business Services, IT, Quality & Regulatory Affairs

Name

Position

Kevin Ronald SayerCEO

Executive Chairman, Chief Executive Officer & President

Michael Jon Brown

Executive Vice President & Chief Legal Officer

Sean Christensen

Vice President of Finance and Investor Relations

Matthew Dolan

Executive Vice President of Strategy, Corporate Development & Dexcom Labs

Leverne Marsh

Executive Vice President of Marketing

Sadie M. Stern

Executive Vice President & Chief Human Resources Officer

Jereme M. Sylvain CPACFO

Executive Vice President, Chief Financial Officer & Chief Accounting Officer

Donald M. Abbey

Executive Vice President of Global Business Services, IT, Quality & Regulatory Affairs

Management Team

Kevin Ronald SayerCEO

Executive Chairman, Chief Executive Officer & President

Michael Jon Brown

Executive Vice President & Chief Legal Officer

Sean Christensen

Vice President of Finance and Investor Relations

Matthew Dolan

Executive Vice President of Strategy, Corporate Development & Dexcom Labs

Leverne Marsh

Executive Vice President of Marketing

Sadie M. Stern

Executive Vice President & Chief Human Resources Officer

Jereme M. Sylvain CPACFO

Executive Vice President, Chief Financial Officer & Chief Accounting Officer

Donald M. Abbey

Executive Vice President of Global Business Services, IT, Quality & Regulatory Affairs

Management

Kevin Ronald SayerCEO

Executive Chairman, Chief Executive Officer & President

Michael Jon Brown

Executive Vice President & Chief Legal Officer

Sean Christensen

Vice President of Finance and Investor Relations

Matthew Dolan

Executive Vice President of Strategy, Corporate Development & Dexcom Labs

Leverne Marsh

Executive Vice President of Marketing

Sadie M. Stern

Executive Vice President & Chief Human Resources Officer

Jereme M. Sylvain CPACFO

Executive Vice President, Chief Financial Officer & Chief Accounting Officer

Donald M. Abbey

Executive Vice President of Global Business Services, IT, Quality & Regulatory Affairs

Total 8 executives

DXCM Frequently asked questions

What is DexCom, Inc. (DXCM) Stock Price?

Current stock price of DexCom, Inc. (DXCM) stock is $89.690. The stock price is -0.50% lower in the session. The intraday range can be seen from this page. Volume of DexCom, Inc. (DXCM) stock is 1.79M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the DexCom, Inc. (DXCM) stock price going up or down today?

The stock price of DexCom, Inc. (DXCM) can change with earnings, company news, and overall market sentiment. DexCom, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the DexCom, Inc. stock expensive at its current price?

Whether DexCom, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for DXCM on this page is 35.17. EPS on this page is 2.55. Compare those figures with peers and growth expectations before deciding if the current DexCom, Inc. price is justified.

How has the stock price of DexCom, Inc. (DXCM) performed historically?

Historical performance for DexCom, Inc. (DXCM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how DXCM reacted to past earnings and market events.

Should I buy DexCom, Inc. (DXCM) stock, at this price?

Buying DexCom, Inc. (DXCM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.